Grifols S A SEC Filings

Welcome to our dedicated page for Grifols S A SEC filings (Ticker: GRFS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Grifols, S.A. (GRFS) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, primarily on Form 20‑F and Form 6‑K. As a foreign private issuer and global healthcare company focused on plasma-derived medicines and transfusion medicine, Grifols uses these filings to report financial performance, governance decisions and other material information to investors.

In its recent 6‑K reports, Grifols has provided half‑year and quarterly results that detail revenue trends, adjusted EBITDA, free cash flow and leverage metrics. These filings show how the Biopharma segment, led by immunoglobulin, albumin, Alpha‑1 and specialty proteins, contributes to growth, and how the Diagnostic business performs in areas such as blood typing solutions and molecular donor screening. They also describe the company’s Value Creation Plan, deleveraging efforts and liquidity position.

Other 6‑K submissions cover board and governance matters, including amendments to the internal regulations of the Board of Directors, the renaming and expanded remit of the Sustainability, Communication and Reputation Committee, and changes in the secretary and vice‑secretary roles of the Board. Dividend declarations, such as the approval of an interim cash dividend, are also disclosed through these reports.

On Stock Titan, each Grifols filing is accompanied by AI-powered summaries that explain the key points in accessible language, helping users understand complex financial tables and legal language. Investors can quickly locate annual reports (20‑F), current reports (6‑K) with earnings presentations and press releases, and other relevant documents. Real-time updates from EDGAR ensure that new filings appear promptly, while structured views of the information help users track topics such as revenue mix, leverage ratio, capital allocation and governance changes for GRFS over time.